GSK urges Third Circuit to block Louisiana antitrust case over Flonase
MLex Summary: GlaxoSmithKline has filed an opening brief in its appeal of a decision that allowed the state of Louisiana to bring allegations that the drugmaker delayed the market entry of generic...To view the full article, register now.
Already a subscriber? Click here to view full article